— Know what they know.
Not Investment Advice

CKDXF OTC

Ceryvyn Therapeutics Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -97.7% 1Y: -97.7% 3Y: -97.6% 5Y: -99.1%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 44 · $13.7M mcap · 1.17B float · 0.0001% daily turnover

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 02, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CKDXF receives an overall rating of A. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5), P/B (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-10-03 None ADDED
2026-10-03 EXISTED None
2026-09-29 None ADDED
2026-09-26 EXISTED None
2026-09-22 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-13 EXISTED None
2026-09-09 None ADDED
2026-09-05 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
66
Earnings Quality
0
Growth
48
Value
82
Momentum
0
Safety
0
Cash Flow
29

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-45.63
Distress Zone
Piotroski F-Score
4/9
✓ ✗ ✓ ✗ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
134.18
Bankruptcy prob: 100.0%
High Risk
Credit Rating
BB-
Score: 37.3/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: -2.04x
Accruals: 186.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CKDXF scores -45.63, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CKDXF scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CKDXF's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CKDXF receives an estimated rating of BB- (score: 37.3/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CKDXF's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
0.21x
PEG
—
P/S
532.97x
P/B
0.67x
P/FCF
-0.10x
P/OCF
—
EV/EBITDA
0.06x
EV/Revenue
-276.17x
EV/EBIT
0.06x
EV/FCF
0.05x
Earnings Yield
473.61%
FCF Yield
-965.19%
Shareholder Yield
0.00%
Graham Number
$0.13
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 0.2x earnings, CKDXF trades at a deep value multiple. An earnings yield of 473.6% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $0.13 per share, suggesting a potential 1163% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.116
NI / EBT
×
Interest Burden
-0.467
EBT / EBIT
×
EBIT Margin
-4840.250
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
-3.812
Assets / Equity
=
ROE
-234.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CKDXF's ROE of -234.2% is driven by Asset Turnover (0.000), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.12 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$0.40
Price/Value
0.02x
Margin of Safety
97.52%
Premium
-97.52%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CKDXF's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $0.40, CKDXF appears undervalued with a 98% margin of safety. The adjusted fair P/E of 8.5x compares to the current market P/E of 0.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.01
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.02
Ann. Volatility
165.9%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
10
-70.6% YoY
Revenue / Employee
$2,500
Rev: $25,000
Profit / Employee
$-16,279,100
NI: $-162,791,000
SGA / Employee
$2,053,700
Avg labor cost proxy
R&D / Employee
$12,683,200
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
ROE -63.7% -36.0% -66.8% -86.9% -1.2% -88.3% -58.1% -71.9% -51.2% -73.1% -1.1% -2.9% -1.9% -4.0% -9.7% 160.6% 11.6% 4.1% 4.4% -2.3% -2.34%
ROA -55.8% -33.9% -61.0% -73.2% -96.2% -80.3% -52.9% -62.8% -46.3% -69.6% -1.1% -2.4% -1.2% -2.1% -2.8% -3.5% -2.6% -4.2% -57.1% 61.4% 61.45%
ROIC -19.6% -5.6% -13.6% -5.5% 106.8% -5.5% 46.8% -15.9% 11.3% -2.7% -5.8% -30.9% -52.3% 2.0% 1.7% 3.5% 4.4% 1.3% -552.4% 640.2% 640.23%
ROCE -1.2% -32.0% -61.5% -1.0% -1.4% -2.1% -87.5% -94.5% -33.6% -42.7% -86.6% -2.7% -1.3% -3.0% -3.3% -3.8% -8.6% 1.8% -10.3% -6.1% -6.06%
Gross Margin -41.9% -30.9% -1.8% — — — 25.3% 3.5% 1.0% 3.2% 1.0% -1.7% -54.1% -53.5% 15.9% 18.8% 0.0% -1.2% 0.0% — —
Operating Margin -155.9% -114.7% -270.9% — — — -42.4% 103.0% -636.0% 128.2% -432.0% -1253.3% -1515.3% -1267.3% -1544.1% -1536.0% -3551.7% -28852.5% -7062.0% — —
Net Margin -97.6% -71.8% -231.3% — — — -27.9% 66.7% -843.7% 122.2% -413.4% -1207.5% -1479.6% -1162.1% -1582.1% -1942.4% -5496.6% -12609.6% 339904.0% — —
EBITDA Margin -154.4% -113.6% -270.6% — — — -42.3% 103.0% -636.0% 128.3% -432.0% -1253.2% -1488.0% -1282.3% -1491.4% -1700.6% -4821.5% -3090.5% -7062.0% — —
FCF Margin -9.0% -23.6% -114.8% -209.4% -324.7% -893.9% -109.9% -222.6% -275.7% 2575.8% 640.7% -8893.9% -4411.6% -794.4% -1081.7% -1182.2% -1157.0% -1761.9% -2462.6% -5144.1% -5144.11%
OCF Margin -9.0% -23.6% -114.6% -209.1% -324.3% -892.8% -109.8% -222.5% -275.5% 2575.3% 640.6% -8892.0% -4410.8% -794.3% -1081.5% -1182.0% -1156.7% -1761.7% -2462.2% -5144.0% -5144.02%
ROA 3Y Avg snapshot only -61.36%
ROIC Economic snapshot only -8.78%
Cash ROA snapshot only -5.98%
NOPAT Margin snapshot only -7005.82%
Pretax Margin snapshot only 2261.35%
R&D / Revenue snapshot only 4907.00%
SGA / Revenue snapshot only 1370.31%
SBC / Revenue snapshot only 43.19%
Valuation
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
P/E Ratio — — — — — — — — -7.18 — -3.35 -1.99 -1.98 -0.61 -0.39 -0.41 -0.57 -1.26 -10.79 0.21 0.211
P/S Ratio — — — — — — — — 2327.56 — -2317.07 21088.08 9902.48 591.44 536.40 616.96 1065.01 2962.68 6486.04 532.97 532.966
P/B Ratio — — — — — — — — 2.21 — 2.94 5.50 6.48 -23.67 -3.66 -2.60 -1.67 -2.69 26.05 0.67 0.668
P/FCF — — — — — — — — -8.44 — -3.62 -2.37 -2.24 -0.74 -0.50 -0.52 -0.92 -1.68 -2.63 -0.10 -0.104
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — -3.45 — -2.36 -1.67 -1.65 -0.21 -0.03 -0.35 -0.80 -1.35 -2.44 0.06 0.057
EV/Revenue — — — — — — — — 1246.99 — -1624.73 17520.54 8453.30 211.48 46.59 520.34 1409.26 2697.77 6241.10 -276.17 -276.167
EV/EBIT — — — — — — — — -3.52 — -2.38 -1.69 -1.64 -0.21 -0.03 -0.35 -0.80 -1.35 -2.44 0.06 0.057
EV/FCF — — — — — — — — -4.52 — -2.54 -1.97 -1.92 -0.27 -0.04 -0.44 -1.22 -1.53 -2.53 0.05 0.054
Earnings Yield — — — — — — — — -13.9% — -29.8% -50.2% -50.5% -1.6% -2.6% -2.5% -1.8% -79.1% -9.3% 4.7% 4.74%
FCF Yield — — — — — — — — -11.8% — -27.7% -42.2% -44.6% -1.3% -2.0% -1.9% -1.1% -59.5% -38.0% -9.7% -9.65%
Price/Tangible Book snapshot only 0.668
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $0.13
Leverage & Solvency
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Current Ratio 7.00 27.63 9.98 5.75 5.24 5.66 12.46 10.31 13.73 44.46 12.22 4.98 16.32 5.25 5.10 2.94 1.57 0.22 19.52 13.78 13.782
Quick Ratio 7.00 27.63 9.98 5.75 5.24 5.66 12.46 10.31 13.73 44.46 12.22 4.98 16.32 5.25 5.10 2.94 1.57 0.22 19.52 13.78 13.782
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 1.56 -0.03 -0.00 -1.87 -1.32 -0.00 0.00 0.00 0.000
Net Debt/Equity -0.95 -0.95 -0.96 -0.85 -1.01 -0.69 -1.01 -0.95 -1.02 -0.87 -0.88 -0.93 -0.95 — — — — — -0.98 -1.01 -1.014
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57 0.00 0.00 0.75 1.53 0.00 0.00 0.00 0.000
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.46 -0.00 -0.00 -0.30 -0.48 -0.00 -0.00 -0.00 -0.000
Net Debt/EBITDA 0.79 2.97 1.55 0.82 0.74 0.32 1.16 1.01 2.99 2.00 1.00 0.34 0.28 0.37 0.35 0.07 -0.20 0.13 0.10 0.17 0.167
Interest Coverage — — — — — — — — — — — — -53.93 -18.01 -12.33 -8.41 -6.48 -4.45 -3.15 -2.33 -2.331
Equity Multiplier 1.16 1.04 1.11 1.21 1.23 1.21 1.09 1.11 1.08 1.02 1.09 1.25 2.73 -16.85 -3.55 -2.49 -0.86 -0.28 1.05 1.08 1.078
Cash Ratio snapshot only 12.957
Debt Service Coverage snapshot only -2.331
Defensive Interval snapshot only 48.8 days
Efficiency & Turnover
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Asset Turnover 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — 773402.00 — — — 281318.00 — — — —
Receivables Turnover (trade) 1.74 0.24 — 0.02 0.02 0.01 0.13 0.01 0.04 -0.00 -0.08 0.00 0.07 0.11 0.64 0.05 0.06 0.03 0.19 0.00 0.004
Payables Turnover — 0.37 — 0.07 0.04 0.04 0.07 0.11 0.10 0.24 0.11 0.08 0.15 0.04 0.03 0.02 0.01 0.01 0.00 0.00 0.001
DSO (trade) 210 1504 0 21128 15943 67030 2781 26574 8516 -101657 -4837 88451 4904 3403 566 6765 6084 14140 1880 89475 89475.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 0 975 0 4908 8150 9256 5064 3303 3777 1530 3237 4316 2505 8661 14452 23799 25094 31672 73987 252168 252168.4 days
Cash Conversion Cycle (trade) 210 529 0 16220 7792 57774 -2284 23271 4739 — — 84135 2399 -5258 -13886 -17034 -19011 -17531 -72106 -162693 -162693.1 days
Cash Velocity snapshot only 0.001
Capital Intensity snapshot only 860.639
Growth (YoY)
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue 13.8% -28.7% -80.5% -86.4% -86.6% -88.0% 61.1% 17.3% 1.0% -1.5% -1.6% -87.5% -70.9% 14.1% 2.8% 16.5% 3.8% -48.0% -71.8% -92.0% -91.95%
Net Income -72.4% -62.1% -1.3% -1.2% -1.7% -2.0% -62.8% -60.3% -94.1% -1.0% -2.6% -4.2% -3.5% -3.4% -2.6% -1.5% -81.0% -24.8% 87.6% 1.1% 1.13%
EPS 26.3% -44.8% -69.3% -53.7% -61.8% -93.9% -29.4% -27.3% -53.3% -51.2% -1.4% -3.0% -1.9% -2.2% -1.3% -30.7% -40.5% 49.8% 94.5% 1.1% 1.07%
FCF 44.4% -4.5% -1.9% -2.0% -3.8% -3.5% -54.3% -24.7% -71.8% -56.3% -2.7% -4.0% -3.7% -3.0% -2.1% -1.3% -26.8% -15.2% 35.8% 65.0% 64.99%
EBITDA -16.1% -17.6% -76.1% -1.5% -2.3% -2.8% -1.4% -54.1% -24.1% -18.5% -87.5% -2.1% -3.1% -3.6% -2.7% -1.5% -65.8% -1.6% 48.1% 73.7% 73.66%
Op. Income -24.3% -35.2% -92.6% -1.6% -2.3% -2.7% -1.4% -54.9% -24.9% -17.6% -86.0% -2.1% -3.1% -3.6% -2.7% -1.4% -52.0% -10.0% 42.9% 65.5% 65.48%
OCF Growth snapshot only 64.98%
Asset Growth snapshot only -88.30%
Debt Growth snapshot only -1.00%
Shares Change snapshot only 1.02%
Growth (CAGR)
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue 3Y — — — — -31.3% -57.3% -24.6% -38.8% -32.4% — — -72.9% -57.1% -5.2% 23.6% 36.9% 41.8% 54.7% -30.8% -44.0% -43.95%
Revenue 5Y — — — — — — — — — — — — -28.2% -11.2% -12.8% -12.9% -15.4% -20.6% -36.4% -51.1% -51.08%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — 49.5% — — — — — — — — — — — -49.0% — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — -36.6% -47.0% — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — 22.6% 25.8% 41.8% 36.0% 73.4% 83.0% 1.0% 1.2% 95.3% 72.4% 1.4% 37.9% 51.1% 60.0% 43.8% 14.7% -33.4% -32.5% -32.52%
Assets 5Y — — — — — — — — — — 41.8% 30.4% 67.6% 58.2% 61.0% 74.3% 41.4% 25.2% 3.3% 5.3% 5.31%
Equity 3Y — — 23.1% 25.4% 39.6% 36.4% 81.6% 93.3% 1.1% 1.2% 93.6% 67.0% 82.0% — — — — — -32.6% -31.9% -31.88%
Book Value 3Y — — -22.3% -22.5% -19.1% -22.5% 7.8% 12.3% 20.8% 69.2% 42.9% 25.9% 22.3% — — — — — -61.3% -60.4% -60.37%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue Stability 0.90 0.93 0.06 0.04 0.05 0.89 0.51 0.57 0.65 0.95 0.06 0.03 0.25 0.42 0.37 0.37 0.41 0.20 0.51 0.61 0.608
Earnings Stability 0.34 0.37 0.87 0.85 0.69 0.68 0.90 0.89 0.79 0.78 0.66 0.58 0.60 0.60 0.63 0.69 0.77 0.82 0.26 0.10 0.097
Margin Stability 0.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.90 0.50 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.39 0.41 0.13 0.22 -0.22 -0.85 0.02 0.08 0.51 0.30 -0.41 -2.17 -2.73 — — — — — — — —
Gross Margin Trend -0.02 -0.36 -0.92 -1.07 -1.27 -1.96 0.52 -2.19 -1.26 — — -33.18 -11.74 — — 18.55 7.41 — — 17.44 17.438
FCF Margin Trend 20.38 -4.29 -100.07 -195.64 -311.01 -874.01 -48.72 -113.16 -108.82 — — -8677.89 -4111.44 — — 3376.02 1186.66 — — -106.07 -106.066
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — 1.6% 1.59%
Cash Flow Quality
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 0.53 0.77 0.93 1.13 0.96 1.17 0.88 0.88 0.85 0.89 0.93 0.84 0.88 0.81 0.79 0.78 0.62 0.75 4.10 -2.04 -2.038
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only -2.038
CapEx/Revenue 2.1% 3.6% 24.5% 30.2% 37.2% 1.1% 10.9% 14.9% 13.0% -50.4% -6.6% 1.9% 77.1% 16.2% 19.1% 21.5% 22.8% 21.1% 35.5% 9.9% 9.92%
Accruals Ratio -0.26 -0.08 -0.04 0.09 -0.04 0.13 -0.06 -0.08 -0.07 -0.07 -0.08 -0.39 -0.15 -0.38 -0.59 -0.78 -1.01 -1.04 1.77 1.87 1.867
Sloan Accruals snapshot only -0.983
Cash Flow Adequacy snapshot only -51879.268
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Dividend Yield — — — — — — — — 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — 0.2% — 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield — — — — — — — — -48.9% — -40.4% -43.1% -46.3% -1.2% -2.7% -2.9% -1.2% -64.9% -23.8% -2.5% -2.49%
Total Shareholder Return — — — — — — — — -48.9% — -40.4% -43.1% -46.3% -1.2% -2.7% -2.9% -1.2% -64.9% -23.8% -2.5% -2.49%
DuPont Factors
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 0.73 0.73 0.78 0.60 0.60 0.59 0.54 0.62 0.76 0.84 0.89 0.93 0.95 0.95 0.95 0.96 0.95 0.96 0.83 1.12 1.116
Interest Burden (EBT/EBIT) 0.94 1.00 1.00 0.98 0.97 0.97 0.97 0.98 1.20 1.20 1.14 1.10 1.03 1.00 1.04 1.07 1.11 1.22 0.28 -0.47 -0.467
EBIT Margin -24.37 -42.33 -158.12 -314.82 -585.05 -1344.26 -236.62 -420.91 -354.37 2867.32 681.61 -10397.44 -5139.88 -1022.04 -1387.52 -1479.00 -1761.06 -1997.36 -2555.70 -4840.25 -4840.250
Asset Turnover 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.14 1.06 1.10 1.19 1.21 1.10 1.10 1.15 1.10 1.05 1.09 1.18 1.57 1.94 3.48 -45.71 -4.37 -0.98 -7.79 -3.81 -3.812
Per Share
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $-0.08 $-0.07 $-0.10 $-0.11 $-0.13 $-0.14 $-0.13 $-0.14 $-0.19 $-0.22 $-0.33 $-0.55 $-0.55 $-0.69 $-0.74 $-0.71 $-0.77 $-0.35 $-0.04 $0.05 $0.05
Book Value/Share $0.09 $0.32 $0.22 $0.18 $0.16 $0.12 $0.29 $0.24 $0.63 $0.50 $0.37 $0.20 $0.17 $-0.02 $-0.08 $-0.11 $-0.26 $-0.16 $0.02 $0.01 $0.01
Tangible Book/Share $0.09 $0.32 $0.22 $0.18 $0.16 $0.12 $0.29 $0.24 $0.63 $0.50 $0.37 $0.20 $0.17 $-0.02 $-0.08 $-0.11 $-0.26 $-0.16 $0.02 $0.01 $0.01
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $-0.00 $-0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.04 $-0.06 $-0.10 $-0.12 $-0.12 $-0.17 $-0.12 $-0.12 $-0.16 $-0.19 $-0.30 $-0.46 $-0.49 $-0.56 $-0.58 $-0.56 $-0.48 $-0.26 $-0.17 $-0.10 $-0.10
OCF/Share $-0.04 $-0.06 $-0.10 $-0.12 $-0.12 $-0.17 $-0.12 $-0.12 $-0.16 $-0.19 $-0.30 $-0.46 $-0.49 $-0.56 $-0.58 $-0.56 $-0.48 $-0.26 $-0.17 $-0.10 $-0.10
Cash/Share $0.09 $0.30 $0.21 $0.15 $0.16 $0.08 $0.30 $0.23 $0.64 $0.44 $0.33 $0.18 $0.42 $0.27 $0.27 $0.25 $0.21 $0.04 $0.02 $0.02 $0.02
EBITDA/Share $-0.11 $-0.10 $-0.13 $-0.19 $-0.22 $-0.25 $-0.26 $-0.23 $-0.21 $-0.22 $-0.32 $-0.54 $-0.57 $-0.73 $-0.75 $-0.69 $-0.73 $-0.30 $-0.17 $-0.09 $-0.09
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.26 $0.00 $0.00 $0.21 $0.35 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-0.09 $-0.30 $-0.21 $-0.15 $-0.16 $-0.08 $-0.30 $-0.23 $-0.64 $-0.44 $-0.33 $-0.18 $-0.16 $-0.27 $-0.26 $-0.05 $0.14 $-0.04 $-0.02 $-0.02 $-0.02
Academic Models
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -45.628
Altman Z-Prime snapshot only -100.299
Piotroski F-Score 2 3 1 0 1 0 4 2 3 3 3 2 2 2 2 3 3 2 3 4 4
Beneish M-Score -9.95 114.33 -4.92 — — — -3.09 — — — -5.47 — -4.30 — 10.83 -10.10 29.34 15.92 29.49 — —
Ohlson O-Score snapshot only 134.184
ROIC (Greenblatt) snapshot only -6.06%
Net-Net WC snapshot only $0.01
Credit
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only BB-
Credit Score 77.76 78.06 77.71 77.84 78.78 80.05 57.74 56.78 74.11 53.99 74.13 80.66 26.57 20.00 20.00 20.00 20.00 17.63 70.36 37.29 37.286
Credit Grade snapshot only 13
Credit Trend snapshot only 17.286
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 31
Sector Credit Rank snapshot only 29

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms